PELLICIARI, Davy Henrique Sousa; REIS, Caio Ricco Alves; BORDINI, Carlos Alberto. Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? – a pharmacoeconomic study. Headache Medicine, [S. l.], v. 15, n. Supplement, p. 98, 2024. Disponível em: https://www.headachemedicine.com.br/index.php/hm/article/view/1230. Acesso em: 8 nov. 2025.